trending Market Intelligence /marketintelligence/en/news-insights/trending/FMdP5RwMjbwO_kN2T8o9hA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Revive Therapeutics plans merger with Herman Holdings

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Revive Therapeutics plans merger with Herman Holdings

Revive Therapeutics Ltd., a Canadian company developing cannabinoid-based products, signed a non-binding letter of intent to merge with Herman Holdings Ltd.

Under the terms of the letter, Revive will consolidate its common shares on a 1-for-2.5 basis upon completion of the merger.

The shareholders of Herman Holdings will receive two common shares of Revive for each common share of Herman they hold, including Herman Holdings shares from the company's proposed C$2.5 million private placement. Revive will also issue replacement convertible securities of the resulting issuer to holders of Herman Holdings convertible securities in the same ratio as the common shares.

For purposes of the deal, the deemed value of Revive's issued and outstanding shares at the time of closing shall be about C$6,750,000. The value of issued and outstanding shares of Herman Holdings at closing shall be about C$18.3 million, plus gross proceeds of C$2.5 million from the proposed placement.

The transaction is subject to a definitive agreement between the companies, completion of due diligence, as well as approvals from shareholders, regulators and the Canadian Securities Exchange, among other conditions.

In February, Revive entered into a binding letter of intent to establish a joint venture with Herman Holdings that would extract and market of cannabis oils.

Herman Holdings is an investment company focused on the cannabis sector.

Toronto-based Revive received approval to list on the CSE in July.